Cargando…
A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus
PURPOSE: To compare the safety and efficacy of 0.1% riboflavin in two different solutions which is used in corneal collagen crosslinking (CXL) for the treatment of keratoconus. METHODS: This was a prospective, randomized, comparison study which included 100 eyes of 61 patients with progressive kerat...
Autores principales: | Brar, Sheetal, Ganesh, Sri, Reddy, Shilpa S, BN, Nagesh, Shahanand, Dhwni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232965/ https://www.ncbi.nlm.nih.gov/pubmed/34188439 http://dx.doi.org/10.2147/OPTH.S313647 |
Ejemplares similares
-
Collagen Crosslinking for Keratoconus
por: Tan, Petrina, et al.
Publicado: (2011) -
Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus
por: Beckman, Kenneth A
Publicado: (2021) -
Modulatory Effect of different Riboflavin Compositions on the Central Corneal Thickness of African Keratoconus Corneas during Collagen Crosslinking
por: Mark, Timo, et al.
Publicado: (2014) -
Excimer laser treatment combined with riboflavin ultraviolet-A (UVA) collagen crosslinking (CXL) in keratoconus: a literature review
por: Ezzeldin, M., et al.
Publicado: (2020) -
Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus
por: McKay, Tina B., et al.
Publicado: (2019)